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Detection of Hypoventilation
To the Editor:
The study by Fu et al (November 2004)1 documents well that
supplemental oxygen impairs the detection of hypoventilation by
pulse oximetry, as discussed in the accompanying editorial by
Demers.2 We regularly perform overnight oximetry on inpatients
to screen for sleep apnea/hypopnea and find that the results are
very insensitive if performed using supplemental oxygen. There-
fore, we perform overnight oximetry either using room air or, if
the baseline awake oxygen saturation level is  90%, using only
enough oxygen to bring the awake saturation to approximately
90%.
Fortunately, it is now possible to directly assess hypoventilation
using continuous transcutaneous carbon dioxide tension monitor-
ing.3 We now routinely monitor transcutaneous carbon dioxide
pressure in patients who are at high risk for hypoventilation in our
ventilator weaning program. We find monitoring to be very
helpful during the initial tracheostomy using a mask or during
overnight periods when the patient is not receiving ventilation, as
well as during bronchoscopies. The advantages of monitoring
cutaneous carbon dioxide tension over monitoring with end-tidal
carbon dioxide tension, which we also use, include allowing
continuous measurement, not requiring deep exhalation, and
making accurate measurements in patients with high dead space
ventilation.
The device (CO-OXSYS Monitor, SenTec AG; Therwil, Swit-
zerland) has been used in Europe4,5 and is now available in the
United States (Aspen Medical Products Inc; Irvine, CA). The
monitor allows us to closely follow transcutaneous carbon dioxide
pressure using a small probe that clips on the ear lobe. It usually
takes about 5 min to equilibrate and then tracks carbon dioxide
pressure closely, along with oxygen saturation.
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Aging and Induced-Sputum Cells
To the Editor:
We read with interest the article by Thomas et al1 (December
2004) on the influence of age on induced sputum in normal
subjects. We think that the discussion on the possible physio-
pathologic mechanisms could be deepened. Although an influ-
ence of advancing age on lung cellularity in healthy subjects has
been already described,2 reference values for cell counts in
induced sputum in healthy adults  50 years old are not avail-
able. The possible explanations of the results found by Thomas et
al1 could be an impairment in humoral lung immunity in older
healthy subjects compared with younger healthy subjects,3 and
the presence of a low-grade inflammation in the lower respiratory
tracts of many asymptomatic, older subjects.4 In particular, a
previous study2 has reported in BAL fluid of the older healthy
individuals an increase in CD4/CD8 lymphocytes ratio prob-
ably due to a repeated antigenic stimulation or irritation by
environmental substances of the immune cells in the lower
respiratory tract during the years. The recurrent antigen stimu-
lation on the immune cells in the lung could be demonstrated by
the decreasing with age of CD19 B lymphocytes that represent
the B cells not yet differentiated into antibody-secreting cells,
suggesting that B cells on mucosal surface of airways in older
subjects has been driven to differentiate by previous repeated
antigen stimulations. The low-grade inflammation in the airways
observed in older subjects might be related to the decline in the
lung function that starts in the fourth to fifth decade of life in
normal never-smoker humans. The mechanism by which neutro-
phils are recruited to within the airways in older healthy subjects
is still unclear. A number of neutrophil chemoattractants can be
secreted by inflammatory cells that reside in the airways, and
epithelial cells can release cytokines, such as IL-8, which have a
potent chemoattractant activity for neutrophils.5 Low-grade per-
sistent inflammation may occur because of the loss of factors that
normally down-regulate the inflammatory response to pollutants
communications to the editor
www.chestjournal.org CHEST / 128 / 6 / DECEMBER, 2005 4049
Copyright © 2005 by American College of Chest Physicians 
 on July 21, 2008 chestjournal.orgDownloaded from 
or repetitive antigenic stimulations, combined with advancing
age. Epithelial cells could be a significant source of neutrophil
chemoattractants, which contributes to a low-grade inflammation
in older subjects. Persistent, low-grade inflammation could dam-
age elastin and perhaps lead to the age-associated loss of elastin
fibers. Therefore, considering that many patients affected by
asthma or COPD who increasingly perform induced sputum are
often  50 years old, these findings deserve further investiga-
tions.
Mario Malerba, MD
University of Brescia
Bruno Balbi, MD
Istituto di Gussago Brescia
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Ribavarin Should Be Tested in
Clinical Trials in Combination With
Other Antiviral Agents for Severe
Acute Respiratory Syndrome
To the Editor:
We read with interest the article in CHEST by Chiou et al (July
2005)1 and offer the following comments. The ribavirin-treated
patients had higher lactate dehydrogenase levels, a well-known
adverse prognostic factor in severe acute respiratory syndrome
(SARS). The nonsignificantly higher mortality could be due to
the more severe disease in this group. Viral load, another
important predictor of mortality, was not available.2 Moreover,
Figure 1 seemed inaccurate: the survival in ribavirin-treated
patients should be 0.88 at day 30 (5 of 44 patients died) instead
of 0.71.
Classifying the ribavirin-treated patients into hypoxemic and
nonhypoxemic subgroups (Table 2) and attributing the higher
mortality in the hypoxemic subgroup to ribavirin was problem-
atic, as both subgroups were treated with an identical protocol of
ribavirin. From the data presented, a more likely explanation for
the more severe drop in hemoglobin in the hypoxemic subgroup
was that they had more severe disease. The survival curves in
Figure 4 also appeared inaccurate: the survival in patients with
drop in hemoglobin  2 g/dL should be 0.69 (5 of 16 patients
died) instead of 0.45. Hence, the result of the log-rank test
(p  0.007) needs to be justified.
Only factors that were potentially associated with hypoxemia
were analyzed in Table 2. No univariate or multivariate analyses
on factors related to death were reported. The conclusion that
hemoglobin level was the only factor associated with death was
not supported by the data presented.
In Figure 6, the shaded triangles were supposed to represent
the hemoglobin of patients who were hypoxemic and had re-
ceived ribavirin. There were 22 triangles, but there should only
be 17 patients. In addition, expressing the survival of individual
patients by proportion (y-axis) is difficult to understand.
Therefore, there is no convincing evidence that ribavirin has
contributed to a life-threatening drop in hemoglobin or mortality
in this report. As of today, three independent studies3–5 have
shown ribavirin to have in vitro activities against SARS-corona-
virus, alone or in combination with other agents. Ribavirin should
be tested in future randomized controlled studies in combination
with other potential antiviral agents for SARS.
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A Modified Percutaneous
Tracheostomy Technique Without
Bronchoscopic Guidance
A Note of Concern
To the Editor:
We read with interest the article in CHEST by Paran and
colleagues (September 2004)1 on a modified percutaneous tra-
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